RecruitingNCT06978387

The Association Between Glycemic Metrics and Cardiovascular Markers in Patients With Type 1 Diabetes.


Sponsor

Attikon Hospital

Enrollment

90 participants

Start Date

Jan 15, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

In this cross-sectioanl study, 90 patients aged \>12 years old with T1DM who are on MiniMed 780G system will be included.The investigators aim to assesse the association of patients' adherence to Mediterranean diet (MD) with CGM and insulin metrics, as well as anthropometric measurements, BMI, lipid levels and blood pressure.Moreover, markers of endothelial, cardiovascular and liver function will be also assessed and associated with the use of Minimed 780G and the adherence to MD.


Eligibility

Min Age: 12 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether blood sugar patterns (measured by continuous glucose monitoring) are linked to heart health in children and young people with type 1 diabetes who use an automated insulin delivery system called the MiniMed 780G. **You may be eligible if...** - You have been diagnosed with type 1 diabetes for more than 1 year - You currently use the MiniMed 780G automated insulin pump system - You are over 7 years old - Your HbA1c is below 12.5% - You have attended at least 3 clinic visits in the past year **You may NOT be eligible if...** - You had a diabetic ketoacidosis (DKA) episode in the past 6 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMinimed 780G

patients aged \>12 years old with T1DM who are on MiniMed 780G


Locations(1)

Attikon University General Hospital

Chaïdári, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06978387


Related Trials